Back to all bills
S 1097119th CongressIntroduced
Interagency Patent Coordination and Improvement Act of 2025
Introduced: Oct 29, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
Establishes an interagency task force between USPTO and FDA to share information and provide technical assistance on patents for human drugs and biological products.
Key Points
- 1Creates Interagency Task Force on Patents between USPTO and FDA
- 2Requires memorandum of understanding between agencies
- 3Establishes information sharing on patents, drugs, and biological products
- 4Provides access to FDA information for patent examiners
- 5Includes confidentiality protocols and safeguards
- 6Requires 4-year report on task force effectiveness
Impact Areas
United States Patent and Trademark OfficeFood and Drug AdministrationPharmaceutical industryPatent examination processIntellectual property lawInteragency coordination
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025